Respiration-gated radiotherapy for tumor sites affected by respiratory motion will potentially improve radiotherapy outcomes by allowing reduced treatment margins leading to decreased complication rates and/or increased tumor control. Furthermore, for intensity-modulated radiotherapy ͑IMRT͒, respiratory gating will minimize the hot and cold spot artifacts in dose distributions that may occur as a result of interplay between respiratory motion and leaf motion. Most implementations of respiration gating rely on the real time knowledge of the relative position of the internal anatomy being treated with respect to that of an external marker. A method to determine the amplitude of motion and account for any difference in phase between the internal tumor motion and external marker motion has been developed. Treating patients using gating requires several clinical decisions, such as whether to gate during inhale or exhale, whether to use phase or amplitude tracking of the respiratory signal, and by how much the intrafraction tumor motion can be decreased at the cost of increased delivery time. These parameters may change from patient to patient. A method has been developed to provide the data necessary to make decisions as to the CTV to PTV margins to apply to a gated treatment plan.
I. INTRODUCTION
Respiration gating has been successfully applied to patient treatments, first in Japan [1] [2] [3] and more recently in the United States. 4, 5 In this technique, the imaging and treatment devices are periodically turned on and off, in phase with the patient breathing pattern, in order to restrict the range of positions of the tumor and internal anatomy during imaging and radiation delivery. This virtual restriction of position allows the internal margin component of the CTV to PTV 6, 7 expansion to be reduced, potentially reducing normal tissue toxicity and/or allowing dose escalation and hence increased tumor control. [8] [9] [10] The respiration signal can be monitored in several ways by employing a video camera, spirometer, fluoroscopy, or strain gauge based systems.
For IMRT, gating has the added advantage of possibly reducing unplanned hot and cold spots in the delivered dose distribution. This problem occurs due to the interplay between the motion of the tumor and critical structures and the motion of the MLC leaves used to deliver IMRT. Such motion may produce hot and cold spot artifacts in dose distributions. 11 These artifacts are similar to the motion artifacts seen in computed tomography ͑CT͒ images of moving objects. [12] [13] [14] [15] [16] Reduction of respiratory motion can be achieved using either breathhold techniques 4, [17] [18] [19] [20] [21] [22] or respiration gating techniques. [1] [2] [3] 5, 15, [23] [24] [25] [26] [27] This study concentrates on respiration gating as not all patients can maintain a breathhold for a useful length of time, 4, 15, 23 and respiration gating is less interventional than breath hold. One could also consider an intermediate approach in which the patient may hold his breath for a variable duration depending upon his or her comfort level. Such an approach will be more efficient than respiratory gating and more comfortable for the patient than the breath-hold techniques. This approach may be important for IMRT due to its long treatment times. The efficiency of any of the techniques to reduce the effects of internal motion improves with patient breathing reproducibility. 25 To determine the optimal gating parameters, two binary decisions and one continuous decision need to be made. Gating can be performed at any stage of the breathing cycle, however at inhale and exhale the mobility of internal anatomy is at its minimum ͑consider the gradient of the cosine ͑͒ curve at ϭ0 and ͒, and therefore gating should be performed about the minimum or maximum point of motion. Thus, whether to gate at inhale or exhale is our first decision. The second decision is whether to track the respiratory signal using the amplitude or the phase of the signal. Amplitude gating is when the imaging and treatment are triggered when the breathing trace is at a certain position. In phase gating, the imaging and treatment are triggered when the calculated breathing phase is at a certain angular phase, e.g., 30°before full exhalation. Schematic diagrams of amplitude and phase gating are shown in Fig. 1 . Amplitude gating has the advantage that it is related to the position of the target, which is of course what we want to irradiate during radiotherapy. Neither method gives useful results when the breathing is not reproducible from one cycle to the next.
The third decision is the cost/benefit consideration of how long we wish to extend the delivery time for the sake of decreased tumor motion. The ratio of beam-on time to treatment time is termed the duty cycle. The range of tumor position decreases with duty cycle leading to smaller treatment margins. However, the radiation delivery time increases. As the treatment time increases, the patient throughput decreases, and also the chance of patient motion due to discomfort increases. Any patient motion due to patients adjusting their position negates the potential gains of respiration gating.
The aim of this work is to demonstrate a method to determine the optimal parameters for respiration-gated imaging and therapy on a patient-by-patient basis. These parameters are whether to gate on inhale or exhale, use amplitude or phase tracking, and the optimal duty cycle from which the margins used for planning are to be defined.
II. METHOD AND MATERIALS
The methods presented here are general to all potential gating patients. However, due to the difficulty of segmenting and tracking the tumor with time, this approach is currently applicable only to tumors that move with the same magnitude and phase as the diaphragm, which include liver tumors 28 and lung tumors in the vicinity of the diaphragm. To demonstrate these methods, they have been applied to the data from two elderly male patients with nonsmall cell lung cancer in the right lower lobe of the lung attached to the diaphragm. These patients are referred to as patient A and patient B. Patient A breathed with more diaphragm motion and patient B with less than the average of those studies reviewed by Langen and Jones.
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A. Gating equipment and setup
The gating equipment used was the Varian ͑Varian Medical Systems, Palo Alto, CA 94304͒ Real-time Position Management ͑RPM͒ system version 1.2.2, connected to the Kermath ͑Kermath Manufacturing Company, Richmond, VA͒ simulator with fluoroscopic capability. The RPM system uses an infrared illuminator to highlight infrared reflectors attached to a marker block placed on the patient's abdomen or chest, which is imaged using a CCD camera. The number of expected pixels in each marker is specified. Very high contrast of the reflective markers is observed, which make image segmentation easy. The markers are a calibrated distance apart, and thus absolute motion in the plane perpendicular to the camera can be obtained. The periodic motion of the marker is tracked synchronously with the input fluoroscopy signal from the simulator. The synchronous inputs allow a time correlation of the internal motion seen on the fluoroscopy images and the external marker motion. Figure 2 shows a volunteer in simulation position with the infrared marker box placed on the abdomen. Inset is a picture of the camera used to acquire the motion of the marker box.
B. Data acquisition
A commercially available software package ͑AVI Constructor Version 3.2. Copyright 1996 -99 Michael Caracena, 4412 Pali Way, Boulder, CO͒ was used to extract individual images from the fluoroscopy video ͑avi͒ file. These images were stored as independent indexed image files. Selected images obtained over half of a breathing cycle are shown in Fig. 3 . Information about the extent of motion of the diaphragm in the superior-inferior direction was obtained by determining the vertical position of the diaphragm apex on each image frame using an edge detection algorithm. The apex coordinates were stored in a file along with the corresponding frame number of the image. This procedure was repeated for all of the individual images. The automated tracking was compared with manual tracking as performed by three independent observers, and the results were highly correlated.
During data acquisition, the marker trace was updated at the rate of 30 frames per second while the fluoroscopy images were captured at 10 frames per second. The RPM software calculates both the position and phase of the marker placed on the patient. The three marker trace points corresponding to each image were averaged. The obtained phase and amplitude for each image were stored in a table along with the diaphragm position.
C. Determining phase shift between internal and external anatomy
Radiotherapy based on respiration gating using tracking of external variables, such as chest/abdomen motion or airflow, relies on the existence of a consistent time correlation between the external measurements and internal anatomy motion. This correlation can either be in phase or out of phase, depending on how each individual breathes, whether he or she is a chest or abdomen breather, the position and type of respiration monitoring device, and the anatomical site being tracked. Thus, knowledge of the phase shift between the internal anatomy to be treated and the external anatomy being tracked is essential.
Reproducibility of the marker position upon the skin from day to day is important, as phase shifts are observed between different marker placements in the abdomen and skin. Also, due to the variation in direction, amplitude, and phase correlation of the internal anatomy motion with the marker position, it is important that the internal anatomy for which the motion is determined is the GTV, or else has a known motion correlation to the GTV for situations in which the GTV itself cannot be determined ͑as is often the case with fluoroscopic examinations͒.
The phase difference between the position of the marker and the internal anatomy was determined by aligning the fluoroscopy tracking trace over the marker trace, until a ''best'' match was obtained ͑as judged by the user͒. The number of frames over which the fluoroscopy trace had to be aligned to obtain the best match was determined both in terms of phase and time.
To investigate any systematic phase differences, the phase difference was determined using the above-mentioned technique for a mechanical sinusoidal oscillator. 30 The actual phase difference for the device, in which the marker is rigidly attached to the moving ''target,'' is zero.
D. Determining gating type, position, and duty cycle
The range and standard deviation of positions within the gated portions of the marker trace were determined as a function of duty cycle. The type of gating was chosen from among four different options, namely, amplitude gating at exhale, amplitude gating at inhale, phase gating at exhale, and phase gating at inhale. The thresholds for amplitude gating were incremented in steps from the point of minimum excursion of the marker trace to the point of maximum excursion, yielding range and standard deviation of motion values for duty cycles from 0 ͑ϱ treatment time͒ to 1 ͑normal treatment͒.
Gating thresholds ͑see Fig. 1͒ for phase gating were also similarly varied starting from the minimum phase value to the maximum phase value. For each gating threshold, the program then extracted all data points that were within the gating limits. Range of motion and standard deviation values were calculated from points on the phase-shifted diaphragm positions that occurred within the duty cycle. Plots of duty cycle versus range of motion and standard deviation of po- sition were then generated for amplitude and phase gating at both inhale and exhale points.
The results of the plots of the amplitude and phase for inhale and exhale as a function of duty cycle are needed to determine which part ͑inhale/exhale͒ of the breathing cycle to use, and which gating mode ͑amplitude or phase͒ to use. As the goal is to minimize motion during treatment, the plot with the smallest variation in position as a function of duty cycle is optimal.
Once the inhale/exhale and gating mode decisions have been made, the margins to add to the CTV to create the PTV for the treatment need to be determined. Using the ICRU 62 ͑Ref. 7͒ formalism, the margins to add to the CTV are the internal margin ͑IM͒ and the setup margin ͑SM͒. ͑The internal margin accounts for variations in size, shape, and position of the CTV in relation to anatomical reference points. The setup margin accounts for uncertainties in patient-beam positioning.͒ A discussion of the margin to add to the GTV to obtain the PTV is given in the Appendix.
Antolak and Rosen 31 suggest adding a CTV to PTV margin of 1.65 times the standard deviation of the margin errors. As the IM and SM are independent, the standard deviations of these distributions ͑ IM and SM , respectively͒ should be added in quadrature. Thus the CTV to PTV margin, M, is
Note that IM is composed of intrafraction motion, IMintra , due to respiration, and interfraction displacement, IMinter , due to the differences in the tumor position with respect to the bony anatomy between fractions. IMinter also incorporates interfraction variations in the relation between the internal and external marker. The quantification of IMinter is fundamental and crucial to the success of gating; however, it is beyond the scope of this article and will be addressed in a separate study. For this study we used the estimated IMinter value of 0.2 cm. As IMintra is dependent on the duty cycle, the treatment margin is dependent on the duty cycle. The treatment margin as a function of duty cycle was calculated using our fluoroscopic study data for IMintra ͑as described earlier͒ and Ekberg et al.'s 32 data for SM ͑0.46 cm in the cranio-caudal direction͒. Note also that the margin will vary in the craniocaudal and medial-lateral and anterior-posterior directions.
A flow chart of the parameter extraction methodology is shown in Fig. 4 .
Another factor that needs to be taken into account is the intersession reproducibility of the respiration signal. The reproducibility needs to be established, and a separate margin added for this source of error that is ignored in the current work. We are currently working on ͑a͒ evaluating this error using successive fluoroscopy images of patients taken over different days and ͑b͒ developing audio prompts and visual feedback methods to improve the day to day reproducibility of respiration.
III. RESULTS
A. Determining phase shift between internal and external anatomy
The systematic phase shift of the system was measured by rigidly attaching a marker to a moving sphere. Simultaneously the marker was tracked while a fluoroscopy video was acquired. The motion of the edge of the sphere in the video was then determined. The results are shown in Fig. 5 . Figure 6 shows the marker motion trace and diaphragm before ͑a͒ and after ͑b͒ the phase shift to account for the 
B. Determining gating type, position, and duty cycle
The range of motion as a function of duty cycle for phase and amplitude gating at both inhale and exhale points for patients A and B is shown in Fig. 7 , and standard deviation of motion as a function of duty cycle is shown in Fig. 8 . These graphs show an increasing trend for the standard deviation and range of motion with the increase in duty cycle. Note that the amplitude of diaphragm motion for patient A was nearly three times that of patient B. Another feature that is evident from the figures is that, for a given value of duty cycle, the standard deviation values at inhale are usually greater than those at exhale. This in turn leads to the conclusion that gating during exhale is more reproducible than gating during inhale, which is consistent with results obtained by others. 2, 4 However, this general conclusion may vary from patient to patient, and should be assessed by the current method on an individual basis.
The range of motion and standard deviation of position as a function of duty cycle curves shown in Figs. 7 and 8 may have been improved ͑become more convex and thus decrease motion and increase duty cycle͒ if breathing coaching methods were used.
The treatment margins for a given duty cycle can be determined using either the range of motion results, or standard deviation results. The range of motion analysis gives values that can be used directly as the intrafraction composition of the IM. However, the range of motion is only calculated using the minimum and maximum points, and therefore is very sensitive to outliers that may vary from day to day. ͑This sensitivity is also seen by comparing the smoothness of FIG. 6 . Marker motion and diaphragm edge motion before ͑a͒ and after ͑b͒ the phase shift to account for the time difference between the diaphragm and external skin motion for patient A. The marker motion and diaphragm edge motion for patient B is also shown ͑c͒. Patient B exhibits no phase shift. Note that the amplitude of the marker motion trace is arbitrarily normalized.
FIG. 7.
Range of motion as a function of duty cycle for phase and amplitude gating at both inhale and exhale points for patients A ͑a͒ and patient B ͑b͒. Note that the y-axes on the two plots have different scales. the curves seen in Fig. 8 compared to those of Fig. 7 .͒ The standard deviation of motion can be applied to the margin calculation such that the probability of the tumor being inside the margin during the radiation delivery can be used. 31, 32 All data points are used in the standard deviation of motion analysis, resulting in less sensitivity to outliers than the range of motion values. A limitation of using the standard deviation method is that the distribution assumed ͑normal in our case͒ may not be the best method to characterize the spread of the distribution of values as a function of duty cycle.
Using the amplitude ͑patient A͒ and phase ͑patient B͒ gating at exhale standard deviation ͑ IMintra ) values from Fig.  8 , the CTV to PTV margin was calculated as described in Sec. II. The CTV to PTV margin as a function of duty cycle is shown in Fig. 9 . For patient A, for duty cycle values from 0% to 40% the setup error dominates, from 40% to 60% the setup error and internal motion both affect the margin, and above 60% the margin is dominated by the internal motion. For patient B, the small amplitude of motion means that the CTV to PTV margin is dominated by the setup error for all duty cycle values, and the use of margin would not result in margin reduction.
The final decision is to determine which duty cycle is optimal, by balancing the desired reduction in margins with the corresponding increase in treatment time due to this reduction as the duty cycle is reduced. From the patient results presented here for patient A, a 40% duty cycle would have been selected as any further increase in duty cycle would lead to a greater margin; however, any decrease in duty cycle would not lead to a significantly smaller margin. For patient B the use of gating would not result in decreased CTV to PTV margins, though gating may still be useful in reducing motion artifacts during imaging and ͑IMRT͒ delivery.
The results shown in Fig. 9 are dependent on the setup error, and show that if the intrafraction motion is small compared to the setup error, then the CTV and PTV margin reduction is minimal. The CTV to PTV margin reduction as a function of intrafraction motion and setup error is shown in Fig. 10 . Due to the quadrature summation, the margin will tend to be dominated by the larger component, and thus decreasing setup error is important as well as intrafraction motion. 32͒ data for SM ͑4.6 mm in the cranio-caudal direction͒. 1.65 times the total uncertainty was used to calculate the margin ͑Ref. 31͒. The amplitude gating at exhale data was used for the patient A calculation, and phase gating at exhale data was used for the patient B calculation.
FIG. 10. CTV and PTV margins as a function of the standard deviations of setup error and internal motion. Due to the quadrature summation, the larger of the two quantities has the greatest influence on CTV to PTV margins.
IV. DISCUSSION
A procedure has been developed for the determination of optimal gated radiotherapy parameters. First, the phase shift between motion of the internal anatomy and resultant motion of an external marker is determined. Subsequently the range of motion and standard deviation of position for inhale and exhale, and phase and amplitude gating as a function of duty cycle are determined. Other treatment errors, such as setup error are then included to obtain the CTV to PTV margin as a function of duty cycle. For this relation, the duty cycle value that best compromises decreased margins with increased treatment time can be selected.
The choice of optimal parameters and procedures for gated treatments should not depend solely on their numerical values alone. There are other factors that may need to be considered. For instance, it has been shown 17 that inspiration provides a larger lung volume that means that the fractional treated lung volume is smaller, and also inspiration can provide a greater separation between the tumor and critical structures, such as the spinal cord. Thus, even though the point of exhale may provide the most stable portion of the respiratory cycle, its choice for gating treatments should also consider the increased fraction of lung tissue exposed to higher doses.
An obvious limitation of the current method is that the diaphragm and not the GTV motion is being tracked with time. Thus we are limited to tumors in the lower lobe of the lung or in the liver, which have a similar phase and amplitude of motion as the diaphragm. The segmentation of the GTV from fluoroscopy is a subject of ongoing research.
Also in need of investigation is the quantification of the daily variations between the tumor motion and the external marker. The variations should be included into the calculation of CTV-PTV margins.
APPENDIX: OBTAINING THE CTV FROM THE GTV
The addition of the margin for suspected subclinical disease is, of course, a clinical decision. However, it is common practice for lung tumor cases to add a margin to the GTV that accounts for the suspected subclinical disease, the IM and the SM, thus creating the PTV from the GTV without explicitly specifying CTV. If the IM and SM are known, the margin used for the CTV can be inferred.
Often the GTV to PTV margin is 2 cm in the craniocaudal direction and 1.5 cm in the anterior-posterior and medial-lateral directions. As discussed in the text, the margin to add for the IM and SM is 1.65 times the quadrature sum of the respective standard deviations, thus subclinical extensionϩ1.65ϫͱ IM 
